永赢医药创新智选混合发起A(015915)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-37,637,062.23 |
-61,431,028.91 |
-27,766,422.43 |
-35,976,250.47 |
| 利息合计 |
104,677.04 |
66,286.34 |
90,165.28 |
27,422.91 |
| 其中：存款利息收入 |
104,677.04 |
66,286.34 |
88,258.54 |
27,422.91 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
1,906.74 |
- |
| 投资收益合计 |
-46,411,293.94 |
-51,353,371.68 |
-28,298,077.93 |
-5,610,226.60 |
| 其中：股票投资收益 |
-47,383,322.70 |
-52,123,425.57 |
-28,784,509.38 |
-6,124,908.94 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
45,335.50 |
376.11 |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
926,693.26 |
769,677.78 |
486,431.45 |
514,682.34 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
6,977,661.80 |
-10,899,151.57 |
-1,280,220.65 |
-31,123,395.79 |
| 其他收入 |
1,691,892.87 |
755,208.00 |
1,721,710.87 |
729,949.01 |
| 费用 |
3,816,536.59 |
2,027,374.75 |
2,934,009.85 |
819,548.48 |
| 管理人报酬 |
2,738,389.82 |
1,451,828.12 |
2,079,375.69 |
611,848.83 |
| 基金托管费 |
114,099.52 |
60,492.73 |
86,640.70 |
25,493.73 |
| 销售服务费 |
797,982.83 |
422,999.06 |
589,797.47 |
164,636.71 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
1,135.92 |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
1,135.92 |
- |
- |
- |
| 其他费用 |
164,928.50 |
92,054.84 |
178,195.99 |
17,569.21 |
| 利润总额 |
-41,453,598.82 |
-63,458,403.66 |
-30,700,432.28 |
-36,795,798.95 |
微信公众号
证券之星APP
基本资料
